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Abstract. Invariant (Ii) chain is a  membrane-spanning 
protein that is found associated intracellularly with 
class II histocompatibility antigens. 
In the endoplasmic reticulum Ii chain spans the 
membrane and exposes the NH2 terminus on the cy- 
toplasmic and the COOH terminus on the lumenal 
side. This orientation across the membrane is demon- 
strated directly with the monoclonal antibody In-l, 
which exclusively recognizes the NH2 terminal cyto- 
plasmically exposed part of Ii chain. 
Membrane insertion of Ii chain requires signal rec- 
ognition particle and docking protein. When tested in 
a wheat germ cell free system, signal recognition parti- 
cle arrests translation of Ii chain. No signal sequence 
is cleaved from Ii chain upon membrane insertion. 
~ 
ECRETORY and many membrane-spanning proteins are 
translocated across or inserted into the membrane of 
the endoplasmic reticulum (ER) ~ in a  co-translational 
manner (for review see  references 3,  21,  35,  50,  and  51). 
Translocation requires a signal sequence on the nascent poly- 
peptide chain and specific receptors, the signal  recognition 
particle (SRP) and the docking protein (DP) or SRP receptor 
(1, 2, 6,  18,  19, 32,  33,  38, 46-49). SRP has been shown to 
interact with polysomes holding nascent preprolactin chains, 
and it has been proposed that SRP binds to the signal sequence 
(46).  When  probed in  a  wheat germ  cell  free system with 
prolactin or IgG light chain mRNAs, SRP arrests the peptide 
elongation after 70-80 amino acids have been polymerized 
(33, 47, 48). Elongation proceeds after SRP has bound to the 
DP, which is located in the ER membranes (18,  19, 33). 
Cleavable signal  sequences have also been found on pro- 
teins that span the membrane once and expose the carboxy 
(COOH) terminus on the cytoplasmic and the amino (NH2) 
terminus  on  the  extracytoplasmic side  of the  membrane. 
Examples of these types of proteins, which we call here type 
I membrane proteins, are the G protein of vesicular stomatitis 
virus (24, 30, 37) and class I and II histocompatibility antigens 
(12,  29).  The PE2 glycoproteins of Semliki Forest virus and 
Sindbis virus seem to have an uncleaved signal sequence (5, 
i 6, 17). For the PE2 protein of  Sindbis virus, an SRP-mediated 
membrane insertion has been found (5). Translocation of the 
NH2-terminal portion of type I membrane proteins is thought 
to proceed in a manner identical to that of secretory proteins 
1.  Abbreviations  used in  this paper."  Con  A,  coneanavalin A;  DP,  docking 
protein;  ER,  endoplasmic reticulum; li,  invariant;  SRP,  signal recognition 
particle;  TCA, trichloroacetic acid. 
(21,  35,  51).  They become, however, arrested in  the mem- 
brane  by  a  hydrophobic  stop  transfer  sequence,  which  is 
usually located close to the NH2-terminal end of the protein 
(4,  13, 51). 
No cleavable signal sequence has generally been found on 
proteins that span the membrane once and expose the NH2 
terminus on the cytoplasmic and the COOH terminus on the 
extracytoplasmic side.  Among the investigated proteins are 
the  influenza  neuraminidase  (8,  15), the  rat  and  human 
asialoglycoprotein receptor (9, 20, 41), and the human trans- 
ferrin receptor (39). These proteins we call type II membrane 
proteins.  We  are  interested  in  the  question  of how  these 
proteins become integrated into the membrane. 
Invariant (li) chain (also called l-r-chain) is thought to be a 
type II membrane-spanning glycoprotein (13, 31). It is found 
intracellularly assembled with  mouse Ia and  human  HLA- 
DR (class II) histocompatibility antigens (23, 25, 27, 34, 43). 
Assembly of li chain with class II antigens occurs already in 
the ER (27, 43). During the intracellular transport, the oligo- 
meric complex disassembles  and only class II antigens appear 
on the cell surface, li chain seems to remain in a yet uniden- 
tified intracellular compartment (27, 43). 
The complete sequences of  human and mouse Ii chain have 
been determined (11,  31,  40,  42).  DNA  sequence analysis 
shows that Ii chain contains a single stretch of hydrophobic 
amino acids, and this is located between residues 31 and 56. 
Based on this finding, it has been proposed that Ii chain spans 
the membrane close to the NH2 terminus and exposes the 
NH2 terminus on the cytoplasmic side of the membrane (11, 
40, 42).  Here we provide direct experimental evidence that 
the mouse li chain exposes its NH2  terminus on the cyto- 
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into the membrane in an SRP-dependent manner. 
Materials and Methods 
Materials 
Concanavalin  A (Con A)-Sepharose  and protein  A-Sepharose  were obtained 
from Pharmacia,  Uppsala, Sweden; guanidinium-hydrochloride  was from Be- 
thesda Research Laboratories, Bethesda, MD; [3SS]methionine  and ENHANCE 
were from New England Nuclear, Boston, MA; 7-methyl-guanosine-5'-mono- 
phosphate  and  phenylmethylsulfonyl  fluoride  were  from Sigma,  Mtinchen, 
FRG.;  oligo (dT)-cellulose (type II) was from Collaborative  Research,  Inc., 
Waltham,  MA; proteinase K was from Merck, Darmstadt,  FRG.; RPMI  1640 
was from Gibco, Bio-Cult Ltd., Paisley, Scotland; Staphylococcus  aureus V8 
protease  was from Miles GmbH, Frankfurt,  FRG.;  tunicamycin  was from 
Calbiochem, Giessen, FRG. 
Monoclonal  antibody  In-l  has been  described previously (26) and was a 
generous gift from Giinther  H~immerling. 
Methods 
mRNA Purification and Size Fractionation.  Total  mRNA was isolated from 
the  spleens of SL2  mice by a  modified  guanidinium  hydrochloride  method 
(10). Approximately 20 g of frozen spleens were homogenized in 200 ml 6 M 
guanidinium  HCI/1 mM dithiothreitol/20  mM NaAc pH 7.0 (buffer I), using 
a Sorvall Omni-mixer at full speed for pulses of 30-s each. The homogenate 
was centrifuged for 5 rain  at  5,000 g at 4"C. The resulting supernatant  was 
adjusted  to pH  5.0 with 4  N acetic acid and the RNA  was precipitated  by 
adding half a volume of ice-cold ethanol.  Insoluble material was collected by 
centrifugation  and dissolved in  100  ml of buffer  1,  adjusted  to pH  5, and 
reprecipitated as above. After centrifugation, the pellet was dissolved in 10 ml 
50 mM Tris/HCl,  pH 7.5, 120 mM NaCl, 5 mM EDTA,  1% SDS (buffer 2), 
and extracted twice with phenol/chloroform.  Poly (A)  + RNA was obtained by 
affinity chromatography  on an oligo(dT)-cellulose  column, mRNA was size 
fractionated by sucrose gradient centrifugation.  Fractions enriched in mRNA 
that code for Ii chain were identified by cell free translation  (see below) and 
immunoprecipitation  (12). 
Cell Free Protein Synthesis. Total or size fractionated mRNA was translated 
in a wheat germ cell free system (36). The system was supplemented with either 
2 A2~o U/ml of  dog pancreas microsomes, pretreated with micrococcal nuclease 
and high salt, and/or 0.1  A2ao/ml of gradient-fractionated  SRP (48). Micro- 
sprees were prepared  and treated  as described previously (16, 32). SRP was 
prepared  essentially  as described  (48) with  the  exception  that  Nikkol  was 
omitted in the fractionation  on DEAE Sepharose and in the sucrose gradients. 
Except when otherwise stated, cell free translation  was done at 25"C. Proteins 
were analyzed by SDS PAGE (28) and bands were visualized by fiuorography 
(7) using ENHANCE. 
Cell Culture and Labeling of  Cells. B-lymphoma cells (CH I. l.) were cultured 
in  RPM1 1640 medium containing  8%  fetal calf serum,  l0  U  penicillin/ 
streptomycin,  10 #M mereaptocthanol.  Cells were washed twice in methionine- 
free medium and incubated  for 20  min at 37"C in the same medium.  [3sS] 
Methionine  was added to a final concentration  of 400 #Ci/ml, and the cells 
were incubated at 37*(2 for 60 min. Cells were washed and then solubilized in 
ice-cold 50  mM Tris-HC1 buffer  (pH 7.5) containing  0.15 M NaCl,  5 mM 
MgCl~, 1% Triton X-100. Protease inhibitor phenylmethylsulfonyl fluoride was 
added to a final concentration  of 20 ~g/ml.  Debris were removed by centrif- 
ugation at 4"C for 15  rain in a microfuge, and the supernatant  was used for 
immunoprecipitation  and SDS PAGE. In some experiments  glycosylation of 
asparagine  residues was blocked  by adding  tunicamycin  to the cell culture 
medium to a final concentration  of 3 ug/ml. After incubation  for 150 rain at 
37°C, cells were labeled as described above. 
Protease Treatments. A lysate (0.5 ml) derived from 2 x  l06 CHl.l. cells 
was treated  with different  amounts (5-50 ~g) of Staphylococcus  aureus V8 
protease for 15 min at 30"C. Proteolysis was stopped by addition  of trichlore- 
acetic acid (TCA) to a final concentration  of 10%. The TCA precipitate  was 
washed  twice  with  10%  TCA/50%  acetone  to  remove the  detergent  and 
solubilized in 25/~l of sample buffer containing 3% SDS (3). After SDS PAGE, 
the proteins were transferred onto nitrocellulose filters (44). 
In vitro synthesized proteins were digested with protease by adding  1 vol of 
2% Triton X-100,  100 mM Tris HCI, oH 7.5, 300 mM NaCI, and Staphylo- 
coccus aureus V8 protease to a final concentration  of 50 #g/ml and incubating 
the sample for 15 rain at 30"C. Proteolysis was stopped by addition of phenyl- 
methylsulfonyl  fluoride  (20  #g/ml).  For proteolysis  of immunoadsorbed li 
chain, In-1 antibody and protein  A-Sepharose were added to either a CH 1.1. 
cell lysate or a cell free lysate (12). The mixture was incubated for 60 rain and 
the Sepharose beads with bound IgG and Ii chains washed and resuspended in 
20 #1 of l0 mM Tris-Ha pH 7.5 and 50 ~g/ml of Staphylococcus  aureus V8 
protease. After incubation  for 15 rain at 30"C, protein fragments were imme- 
diately analyzed by SDS PAGE. 
lmmunoblotting.  Proteins  were electrophoretically  transferred  from SDS 
polyacrylamide gels onto a nitrocellulose filter (44). The nitrocellulose filter 
was washed twice for 20 rain in phosphate-buffered  saline (PBS) containing 
10% newborn calf serum, then treated for 90 min with cell culture supernatant 
containing In-1 antibody, washed 4x in PBS/newborn calf serum and once in 
PBS/newborn calf serum containing 0.05% Triton X-100. Bound antibody was 
detected with rabbit anti-rat lgG coupled to horseradish peroxidase and stained 
with diaminobenzidine  (44). 
Binding of Proteins to  Con A-Sepharose.  After translation  of spleen cell 
mRNA  in  a  25-~1 wheat  germ  cell free system  in  the  presence  of rough 
microsomes, membranes were pelleted by centrifugation  for 20 rain at 10,000 
rpm at 4"C, They were then solubilized in 0.5% Triton  X-100, 150 mM NaCI, 
50  mM  Tris-HCl,  pH  7.5,  1 mM  CaCI2,  1 mM  MnCI2, and  4  ug/ml of 
phenylmethylsulfonyl fluoride and then 50 #1 of Con A-Sepharose was added 
(a slurry containing beads to solubilization buffer in a 1  : 1 ratio). The mixture 
was incubated for 60 min at room temperature.  Beads were then washed three 
times with  100 mM acetate  at pH 6,  150  mM  NaCI,  1 raM  MnC1,  1 mM 
CaCI2, and  1 mM MgCI2. To the pelleted beads sample buffer for SDS PAGE 
was added and proteins analyzed as described (28). 
Results 
To characterize the disposition  of Ii chain across the mem- 
brane  of the ER, we translated  mRNA from mouse spleen 
cells  in  a  wheat  germ  cell  free  system  in  the  presence  of 
microsomal membranes derived from dog pancreas. In such 
a system membrane proteins become inserted into the mem- 
brane asymmetrically in the same way as in the cell and the 
orientation across the membrane can be determined by pro- 
tease treatment (24, 37). Protease will cleave only that part of 
a membrane protein that is exposed on the cytoplasmic side, 
whereas the lumenally disposed part is protected by the mem- 
brane.  The orientation of the protein across the membrane 
can  then  be  deduced,  if the  means  exist  for detecting  the 
COOH or NH2 termini of the protein. Since we could make 
use of a monoclonal antibody specific for Ii chain, we tested 
whether the antibody recognizes exclusively either the lumen- 
ally or the cytoplasmically disposed portion of Ii chain. De- 
pending on the location of the antigenic determinant of In- 1 
we would be able to discriminate between the two possible 
orientations of Ii chain across the membrane. 
Mouse li Chain Spans the Membrane 
When spleen mRNA is translated in the wheat germ cell free 
system  and  labeled  proteins  are  immunoprecipitated  with 
monoclonal In-1 antibody, a 25-kD form of Ii chain is selected 
(Ii')  (Fig.  !,  lane  I).  When  translation  is performed  in  the 
presence of microsomal membranes, a  3 l-kD protein is syn- 
thesized and this has the same molecular weight as the au- 
thentic Ii chain synthesized in vivo (Fig.  1, lane 2). The latter 
form is glycosylated,  whereas the former is not (see below). 
Both forms have been described previously (40).  Due to the 
binding to protein A  or Con A, the heavy chains of IgG are 
also precipitated  (Fig.  1,  lanes  1,  2,  3,  5,  and  6).  IgG  is  a 
typical  secretory  protein  that  is  translocated  across  micro- 
spinal  membranes  and  therefore  can  be  used  to  assess  the 
intactness of the microsomal membranes. After digestion with 
proteinase K  no Ii chain-related protein  can be precipitated 
with  In-1  antibody  (Fig.  1,  lane  3).  Heavy  chain  of  IgG, 
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solubilized microsomal vesicles, mRNA from mouse spleen cells was 
translated in a wheat germ cell free system in the absence (lane 1) or 
presence of dog pancreas microsomal membranes (lanes 2-7). After 
translation,  proteinase K, 0.5 mg/ml final concentration (lanes 3 and 
6),  or proteinase K  and 0.5%  Triton  X-100 (lanes  4  and  7) were 
added and the mixture incubated for 15 min at 30°C. Ii chain was 
immunoprecipitated using  In-i  antibody and protein A-Sepharose 
(lanes  1-4).  Glycoproteins were  isolated  by  binding  to  Con  A- 
Sepharose  (lanes 5-7). Antigens were separated by SDS PAGE and 
visualized by fluorography.  Ii, membrane inserted  and glycosylated 
invariant chain, li', unglycosylated  form of Ii chain.  H, heavy chain 
of IgG that binds to protein A-Sepharose and Con A-Sepharose. 
however, is readily precipitable, demonstrating that a protec- 
tion against protease digestion has been obtained for proteins 
located in the lumen of microsomal vesicles. When Triton X- 
100 is used together with proteinase K, the lumenally located 
heavy chain  of IgG is digested,  indicating  that protection  is 
dependent  on  the  intact  membrane  barrier (Fig.  l,  lanes  4 
and  7). 
The inability for In-1 antibody to precipitate Ii chain after 
protease  digestion  of intact  microsomes could  indicate  that 
the antibody recognizes the part of the polypeptide chain that 
is  exposed  on  the  cytoplasmic  side  of the  membrane.  To 
detect processed Ii chain, we used Con A-Sepharose. Ii chain 
is known to be glycosylated and should therefore bind to Con 
A  (43).  It furthermore  is the  major 35S-labeled glycoprotein 
synthesized  by spleen  cells and  should  therefore  be  readily 
detectable among the spleen cell glycoproteins. Fig.  1, lane 6 
shows  that  this  is  indeed  the  case  and  that  proteinase  K 
treatment of microsomal vesicles reduces the size of Ii chain 
by  ~3  kD.  This  reduction  in  size  indicates  that  mouse  Ii 
chain,  as  its  human  counterpart,  spans the  membrane  and 
exposes ~30 amino acid residues on the cytoplasmic side of 
the  membrane.  This result also demonstrates  that the  cyto- 
plasmic portion is essential for the recognition of Ii chain by 
In-1 antibody. 
ln-I Antibody Recognizes the NH2-Terminal Portion 
of Ii Chain 
To determine the recognition site for In- 1 on Ii chain, proteo- 
lytic fragments of Ii chain were generated using Staphylococ- 
cus aureus V8 protease. 
Mouse CH 1.1. cells, which express relatively large amounts 
of Ii chain, were labeled for 1 h  with [3SS]methionine and Ii 
chains were precipitated with In-1 antibody.  Immunoprecip- 
itated polypeptides were characterized by SDS PAGE, either 
directly (Fig.  2, lanes 1 and 4) or after treatment with 5 ug/ 
ml (Fig.  2, lane 2) or 50 ug/ml (Fig.  2,  lane 3) 78  protease. 
As expected, Ii chain and a  41-kD protein were precipitated 
with the In-1  antibody (26,  52,  53). The 41-kD protein is an 
Ii gene product generated most likely by differential splicing 
(52).  With  increasing  concentrations  of the  V8  protease,  Ii 
chain was digested into three major polypeptides, labeled A, 
B, and C  (Fig.  2).  Polypeptide A  has a  molecular weight of 
~29 kD, B of~20 kD, and C  of ~10 kD. It appears that the 
cleavage of A generates fragments B and C  adding up to the 
molecular weight of 29 kD. 
To  obtain  information  about  the  location  of the  three 
proteolytic  fragments in the linear structure  of the  Ii chain, 
the same digestion was performed on [35S]cysteine-labeled Ii 
chain. A single cysteine residue is known to occur in Ii chains 
and this residue is located in the NHz-terminal portion  (11, 
31, 42). Fig. 2, lanes 5-7 shows the results obtained with [35S] 
cysteine-labeled Ii chains before (lane 5) or after the digestion 
with 5 ug/ml (lane 6) or 50 ug/ml (lane  7) of V8 protease. Ii 
chain  and  the  fragments A  and  C  are  radioactively labeled 
with  cysteine,  but  not  fragment  B.  Thus,  Staphylococcus 
aureus V8  protease cuts the Ii chain  essentially twice giving 
rise to three polypeptides labeled A, B, and C in Fig. 2. 
To demonstrate the location of the fragment C  within the 
polypeptide chain directly, we introduced a  gradient of label 
into Ii chain,  mRNA from spleen cells was translated in the 
presence of microsomal membranes.  1 min after the start of 
translation,  7-methyl-guanosine  was  added  to  synchronize 
mRNA  translation.  After  different  time  intervals  (Fig.  3), 
unlabeled methionine  was added to a  final concentration  of 
Figure 2. Digestion  of Ii chain with Staphylococcus aureus V8 pro- 
tease.  Mouse CHI.I. cells were  labeled  for  1 h  with  either  [35S]- 
methionine (lanes 1-4) or [35S]cysteine (lanes 5-7). Ii antigens were 
immunoprecipitated and incubated with no proteas¢ (lanes 1, 4, and 
5) or with 5 t~g/ml (lanes 2 and 6) or 50 ~g/ml V8 protease (lanes 3 
and 7) for 15 rain at 30"C. The positions ofglycosylated Ii chain, the 
41-kD polypeptide,  and fragments A, B, and C which are generated 
upon cleavage with Staphylococcus aureus V8 protease are indicated, 
Lipp and Dobberstein  Membrane  Junction of  li Chain  2171 60 
50- 
0 
x  ~ 
~0- 
.~30- 
I 
2 j. 
A/  y"  o/. 
C  ~  x  ~  ~  ~  x  x  x  x 
0  2  /,  6  8  10  12  14  16  18 
~n. of pulse 
130 
§ 
11o ~ 
90 
Figure 3. Pulse labeling of Ii chain  and its fragments generated by 
Staphylococcus aureus V8 protease  digestion,  mRNA from mouse 
spleen cells was translated  in a wheat germ cell free system in the 
presence of dog pancreas microsomes with [35S]methionine as label. 
To synchronize  translation  7-methyl-guanosine-5'-monophosphate 
was added after  1 min.  Different lengths of pulse were achieved by 
adding  unlabeled  methionine  at the times  indicated  in the figure. 
Antigens were immunoprecipitated  as described, digested with 10 ~g/ 
ml V8 protease for 15 rain at 30"C, and characterized by SDS PAGE 
and fluorography. Radioactivity in bands A (O), B (O), and C (x) (see 
Fig. 2) was quantitated  by densitometry.  The constant amount of 
label in  peptide  C indicates  that it  is localized close to the NH2- 
terminal  end. Two scales were used because of different amounts of 
label in the fragments A, B and C. 
10 mM to chase the radioactive methionine. The Ii chain was 
immunoprecipitated, digested with Staphylococcus aureus V8 
protease,  and characterized by SDS PAGE and autoradiog- 
raphy.  The amount of label  in  fragments A, B,  and C  was 
then determined by densitometry of the autoradiograph (Fig. 
3).  It can be predicted that label in a  polypeptide fragment 
located close to the NH2-terminal end will remain constant, 
whereas  label  in  fragments located  close to the  COOH-ter- 
minal end will increase with time of  the pulse. As can be seen 
in Fig. 3, the label in fragment C remains constant while label 
in fragments A  and B increases with the length of the pulse. 
This clearly demonstrates that fragment C is located close to 
the NH2-terminal end of Ii chain. 
To demonstrate that the C  fragment from in vivo synthe- 
sized Ii chain is also recognized by In-1 antibody, we charac- 
terized Ii chain and its fragments by immunoblotting with In- 
1 antibody. Total protein from CH 1.1.  cells either before or 
after digestion with Staphylococcus  aureus  V8  protease was 
separated  by SDS  PAGE,  blotted  onto  nitrocellulose  filter, 
and developed with In-I antibody. Fig. 4 shows that Ii chain 
and the 41-kD protein are recognized by In-1 antibody (lane 
1) as well as after V8 protease digestion the  10-kD fragment 
C  (lane  2).  Thus,  we conclude that  also  in  vivo the  NH2- 
terminal fragment ofli chain carries the determinant required 
for the binding to In-1 antibody. 
To locate the first cleavage site in Ii chain, which removes 
a  segment of ~ 1 kD (see Fig. 2, lane 2),  membrane-inserted 
Ii chain was digested with Staphylococcus aureus V8 protease 
on intact microsomes and then immunoprecipitated.  As no 
molecular weight shift could be detected under these condi- 
tions, it can be concluded that all cleavage sites for V8 protease 
must be located on the lumenal side (data not shown). 
Figure 4.  In-I  antibody recognizes proteolytic 
fragment  C of li  chain  synthesized by CHI.I. 
cells. 1 x  l0  7 mouse CHI.1. cells were detergent 
solubilized and nuclei removed by centrifugation 
at 5,000 g for 10 min. Solubilized antigens were 
treated either with no protease (lane 1) or with 5 
/~g/ml (lane 2) or 50 #g/ml (lane 3) V8 protease 
for 15 min at 30"C and then precipitated  with 
10% TCA, 50% acetone.  After resolubilization 
in SDS-containing sample buffer, proteins were 
separated  by SDS  PAGE.  After  transfer  onto 
nitrocellulose,  proteins  were reacted  with  In-I 
antibody  and visualized by peroxidase-coupled 
anti-rat antibody  and diaminobenzidine  stain- 
ing. 
Figure  5.  Ii  chain  is  synthesized 
without a cleavable signal sequence. 
Mouse CH 1.1. cells were labeled for 
1 h with [35S]methionine in the ab- 
sence (lane 1) or presence (lane 2) of 
3  ~g/ml  tunicamycin  (added  150 
min before labeling), mRNA from 
mouse spleen cells was translated in 
a wheat germ cell free system (lane 
3). Antigens were precipitated  with 
In-I  antibody,  li,  glycosylated  Ii 
chain,  li',  unglycosylated  Ii  chain 
integrated (lane 2) or not integrated 
(lane 3) into membranes of the ER. 
M, molecular weight markers. 
li Chain Is Synthesized without a  Cleavable 
Signal Sequence 
Membrane proteins which expose the NH2 terminus on the 
lumenal side of  the ER are usually synthesized with a cleavable 
signal sequence (35, 51).  In contrast, proteins that expose the 
NH2-terminal end on the cytoplasmic side, like the influenza 
neuraminidase  and  the  rat  and  human  asialoglycoprotein 
receptor, are synthesized without a cleavable signal sequence 
(15,  20,  41).  We  therefore  asked  whether  Ii  chain  is  also 
synthesized without a cleavable signal sequence. In glycopro- 
teins, the presence or absence or a cleavable signal sequence 
can be determined by comparing the molecular weight of the 
translation products synthesized in a  cell free system in the 
absence of microsomal membranes with those synthesized in 
vivo in the presence of tunicamycin. Tunicamycin is known 
to prevent glycosylation but does not interfere with membrane 
insertion and cleavage of a signal sequence. As can be seen in 
Fig. 5, Ii chain is synthesized in CH 1.1. cells in the presence 
of tunicamycin as a  25-kD polypeptide chain. The identical 
molecular weight is found for the Ii chain when it is synthe- 
sized  in  a  wheat  germ  cell  free  system  in  the  absence  of 
microsomal membranes. 
Membrane Insertion of li Chain Is SRP Dependent 
For proteins that are translocated across the membrane of  the 
ER,  it  is  known  that  SRP  and  DP  are  required  for their 
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chain into microsomal membranes.  Spleen 
cell mRNA was  translated  in  the  wheat 
germ  cell free  system  and  synchronized 
after 5 min by 7-methyl-guanosine (lane 1). 
Translation  was  supplemented  with  salt- 
washed  microsomal  membranes  (RMx) 
(lane 2) or SRP (lanes 3 and 4). In lane 4, 
RMK were added after  15 min of synthesis 
in the presence of SRP. 
insertion  into the  membrane  (33,  42).  For one  membrane 
protein,  which  is  synthesized  without  cleavable  signal  se- 
quence, it has been found that SRP and DP are required for 
membrane insertion but no arrest in elongation was observed 
(2).  As demonstrated above, Ii chain is synthesized without a 
cleavable signal sequence, spans the membrane, and exposes 
the NH2 terminus on the cytoplasmic side. We tested therefore 
whether this type of protein requires SRP and DP for mem- 
brane insertion and whether elongation could be arrested by 
SRP. When Ii chain was translated in a wheat germ cell free 
translation system, the 25-kD unglycosylated form ofli chain 
was  synthesized  (Fig.  6,  lane  1).  When  salt-washed  rough 
microsomes, depleted of SRP, were added, no shift of molec- 
ular weight  could be  detected  (Fig.  6,  lane  2).  When  SRP 
alone was added to the cell free translation system, synthesis 
of Ii chain was arrested as well as that of heavy chain of IgG 
(Fig.  6,  lane 3).  The arrest  in  translation  could be released 
when  salt-washed  rough microsomes (RMk)  were added  15 
min after initiation of  translation (Fig. 6, lane 4). Glycosylated 
Ii chains now accumulated. 
amino acid residues in the Ii chain. The remaining 170 amino 
acids are protected by the membrane barrier and must thus 
be  located  on the  lumenal  side  of the  membrane.  (c)  The 
monoclonal antibody In-1 recognizes a  determinant  located 
on a  part of the Ii chain that is exposed on the cytoplasmic 
side of  the membrane. Protease digestion of  intact microsomal 
vesicles destroys this  binding site.  It is  the  NH2 terminally 
located  fragment  C  which  is  recognized by  In-l  antibody. 
Two independent  methods were  used to  locate fragment C 
within Ii chain: (i) After digestion of Ii chain with Staphylo- 
coccus aureus V8 protease,  fragment C  was found to be the 
only one that labeled with [3SS]cysteine.  The only cysteine in 
Ii chain occurs 28 amino acid residues away from the NHE- 
terminal end (see Fig. 7). (ii) When a gradient of [3SS]cysteine 
label  was introduced  into  Ii chain,  the  amount  of label  in 
fragment C  remained constant throughout the chase period. 
This is only consistent with a location of fragment C close to 
NHE-terminal end. (d) There is no cleavable signal sequence 
found in Ii chain.  The unglycosylated precursor of Ii chain 
synthesized in the wheat germ cell free system in the absence 
of microsomal membranes has the identical molecular weight 
as unglycosylated and membrane-inserted Ii chain synthesized 
by  CHI.1  cells.  Cleavable  signal  sequences  have  a  length 
between  13 and 45 amino acid residues (45). A difference of 
five amino acids would have been detected by the SDS PAGE 
system used. 
These  facts  demonstrate  that  Ii  chain  exposes  the  NHE- 
terminal end on the cytoplasmic and the COOH-terminal end 
on the lumenal side of the membrane of the ER. 
In-1  antibody  has  previously been  used  to  locate  the  Ii 
chain on the cell surface (26). As this antibody, however, does 
not recognize a determinant exposed on the external surface 
of the  cell,  it  must  be  concluded  that  broken  cells  were 
responsible for the observed binding of In- l  antibody. Using 
fluorescence activated cell sorter analysis, no surface labeling 
could be detected using this antibody (Arnold, B., and J. Lipp, 
unpublished results). 
Discussion 
Orientation of li across the ER Membrane  C00H 
Several  lines  of evidence  suggest  that  Ii  chain  spans  the  V8---~] 
membrane and exposes the NH2-terminal  end on the cyto- 
plasmic and the COOH-terminal end on the lumenal side of 
the membrane of the ER. (a) Sequence data derived from a 
cDNA for Ii chain locate a  single stretch of 26 hydrophobic 
or uncharged amino acid residues close to the NH2-terminal  >-~ [-"  A 
end (1 l, 31, 42). Hydrophobic sequences are known to occur  4 
in  regions  of proteins  that  span  the  membrane.  (b)  When  V8 
protease is used to digest the cytoplasmically exposed portion  MEMBRANE II 
of li chain, a  segment comprising -30 amino acid residues  ILr 
can  be  removed.  This  segment  corresponds  to  the  length  CYTOPLASM  [[  -cys .~[ 
found between the NH2 terminus and the stretch of  uncharged  -  NH2 
Membrane Insertion of  li Chain, a  Type H 
Membrane-spanning Protein 
Proteins that span the membrane once can expose either their 
COOH-terminal  end  (type  1  membrane  proteins)  or  their 
NH2-terminal end (type 2  membrane proteins) on the cyto- 
plasmic side. Like secretory proteins, type  1 membrane pro- 
teins are usually synthesized with cleavable signal sequences. 
Their  membrane  insertion  proceeds  co-translationally  and 
requires SRP and DP. The same requirements were found for 
B 
'C 
Figure 7.  Schematic  represen- 
tation ofli chain, li chain spans 
the ER membrane and exposes 
the NH2-terminal  end  on the 
cytoplasmic  side  and  the 
COOH-terminal  end on the lu- 
menal side. Proposed locations 
of cleavage sites for Staphylo- 
coccus aureus V8 protease and 
the fragments A, B, and C are 
indicated.  In-I  antibody  rec- 
ognizes that part of  fragment C 
that  is  exposed  on  the  cyto- 
plasmic side. 
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protein. 
What mechanism can be envisaged for a common step in 
membrane insertion of secretory and type 1 and 2 membrane 
proteins? A very attractive possibility, first proposed by Inouye 
and his colleagues for the lipoprotein of Escherichia  coli and 
further extended to membrane-spanning proteins, is that the 
insertion of the NH2-terminal portion of nascent secretory or 
membrane-spanning proteins into the membrane of the ER 
occurs in a loop-like fashion (14, 22, 45). This model is based 
on the assumption that the NHE-terminal end of the signal 
sequence, cleavable or noncleavable, remains exposed on the 
cytoplasmic side of the ER membrane. Cleavage of the signal 
sequence  then  releases  the  new  NH2-terminal  end  of the 
mature protein to the lumen of the ER vesicle. The cleaved 
signal sequence might remain in some or all cases buried in 
the membrane. Type l  membrane-spanning proteins, like the 
H-2 antigens or VSV G protein, have in addition to a cleavable 
signal  sequence  a  second  stretch  of uncharged  amino  acid 
residues located close to the COOH-terminal end. This func- 
tions as a "stop transfer" sequence and anchors the protein in 
the membrane. In type 2 membrane proteins with uncleaved 
signal  sequence the single  hydrophobic segment might per- 
form two functions: (a) as a single sequence mediating SRP- 
dependent  membrane  insertion,  and  (b)  as  a  stop  transfer 
sequence anchoring the protein in the membrane. Certainly 
further direct evidence is required for support of this model 
for membrane insertion of type 2 membrane proteins. 
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